Td Asset Management Inc Ironwood Pharmaceuticals Inc Transaction History

Td Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 01, 2019	SELL	$9.8 - $12.89 $460,766 - $606,049	-47,017 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$8.27 - $12.73 $179,459 - $276,241	-21,700 Reduced 31.58%	47,017 $636,000
Q4 2018 Feb 01, 2019	SELL	$7.8 - $16.13 $1.06 Million - $2.2 Million	-136,449 Reduced 66.51%	68,717 $712,000
Q3 2018 Nov 01, 2018	SELL	$14.31 - $17.65 $336,528 - $415,075	-23,517 Reduced 10.28%	205,166 $3.79 Million
Q2 2018 Jul 31, 2018	SELL	$11.83 - $16.2 $156,156 - $213,840	-13,200 Reduced 5.46%	228,683 $4.37 Million
Q1 2018 May 11, 2018	SELL	$11.13 - $13.63 $998,561 - $1.22 Million	-89,718 Reduced 27.06%	241,883 $3.73 Million
Q4 2017 Feb 02, 2018	BUY	$12.16 - $14.58 $218 - $262	18 Added 0.01%	331,601 $4.97 Million
Q3 2017 Nov 09, 2017	BUY	$12.07 - $14.87 $4 Million - $4.93 Million	331,583	331,583 $5.23 Million

237

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $663M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.